Rivascap
Rivas Capital is a private investment firm focused on long-term principal investments in breakthrough technology businesses.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Rivascap Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2015 | Zipline | Series A | 18M |
| 11/2021 | Comgy | Venture Round | 0 |
| 2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
| 5/2021 | Inari | Series D | 0 |
| 5/2018 | Gamalon | Series A | 20M |
| 3/2022 | NextRNA Therapeutics | Series A | 0 |
| 3/2021 | Clarify Health Solutions | Series C | 0 |
| 10/2018 | Glympse Bio | Series A | 0 |
| 4/2017 | Frequency Therapeutics | Series A | 0 |
| 9/2017 | Greenlight Biosciences | Series D | 18M |
| 3/2020 | Regenacy Pharmaceuticals | Series A | - |
| 4/2018 | Kodiak Sciences | Convertible Note | 33M |
| 4/2018 | ReviveMed | Seed Round | 1.5M |
| 4/2022 | Clarify Health Solutions | Series D | 0 |
| 2/2017 | Gamalon | Seed Round | 4.5M |
| 4/2015 | Aircuity | Venture Round | 0 |
| 8/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
| 9/2016 | Gamalon | Venture Round | 4.4M |
| 6/2011 | Lumicell | Seed Round | 2.7M |
| 9/2015 | N12 Technologies | Series B | 23.2M |
| 1/2016 | Force of Nature Clean | Seed Round | - |
| 4/2014 | N12 Technologies | Venture Round | 5.3M |
| 1/2019 | Frequency Therapeutics | Series B | - |
| 7/2019 | Frequency Therapeutics | Series C | 0 |
| 4/2022 | Clarify Health Solutions | Series D | 0 |
| 3/2022 | NextRNA Therapeutics | Series A | 0 |
| 2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
| 11/2021 | Comgy | Venture Round | 0 |
| 5/2021 | Inari | Series D | 0 |
| 3/2021 | Clarify Health Solutions | Series C | 0 |
| 3/2020 | Regenacy Pharmaceuticals | Series A | 0 |
| 7/2019 | Frequency Therapeutics | Series C | 0 |
| 1/2019 | Frequency Therapeutics | Series B | 0 |
| 10/2018 | Glympse Bio | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
